Documents

THERAPEUTICS AND CLINICAL RISK MANAGEMENT

SPECIAL ISSUE IN SPANISH. SUPPLEMENT I 2006

Therapeutics and clinical risk management 2006 in PDF

Index of articles:

“Use of a new plant extract-based product in acute purulent rhinosinusitis”

BEZSHAPOCHNY S.

“Use of a new plant extract-based product in inflammatory diseases
of the paranasal sinuses. Results of its administration”

KHECHINASHVILI S.

KHOKHASHVILI P.

“Assessment of a new plant extract-based product in rhinosinusitis”

ZARITSKAIA I.           

ZABOLOTNY D.

“Clinical investigation of the efficacy of the use of a new plant-based
product in children with acute rhinosinusitis”

CHARNISHEVA L.           

SINIACHENKO V.

“Use of a new plant extract-based product in the early postoperative
care of patients with productive rhinosinusitis”

POPOVICH V.

SAVCHUK O.

Hartington Pharma owns Nasodren® for sinusitis treatment